Fertility Preservation Legislation in the United States: Potential Implications for Transgender Individuals

Moira A. Kyweluk*, Joyce Reinecke, Diane Chen

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Gender-affirming hormones may compromise gonadal function leading to subfertility or infertility. Fertility preservation (FP; i.e., egg and sperm "freezing") before starting hormones offers future options to transgender individuals. In the United States, FP is extremely expensive and rarely covered by medical insurance; state-specific laws govern required benefits. Recent changes in insurance mandates in Connecticut, Delaware, Illinois, Maryland, New Hampshire, New York, and Rhode Island have expanded FP coverage, but implications of these changes for transgender individuals are unclear. State-by-state advocacy to expand insurance coverage for FP in individuals whose medically necessary treatments compromise fertility should consider the needs of transgender individuals desiring biological parenthood.

Original languageEnglish (US)
Pages (from-to)331-334
Number of pages4
JournalLGBT Health
Volume6
Issue number7
DOIs
StatePublished - Oct 2019

Keywords

  • biological parenthood
  • egg freezing
  • medical insurance
  • sperm freezing

ASJC Scopus subject areas

  • Dermatology
  • Obstetrics and Gynecology
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health
  • Urology

Fingerprint Dive into the research topics of 'Fertility Preservation Legislation in the United States: Potential Implications for Transgender Individuals'. Together they form a unique fingerprint.

Cite this